KUALA LUMPUR, April 1 -- Greater Boston-based biotech, Conagen has received strategic investment from Japan’s Sumitomo Chemical to accelerate Conagen’s synthetic biology research and development contributing to a clean and sustainable planet.
Both Sumitomo Chemical and Conagen share a vision of bio-designing and introducing sustainable green chemicals to the market for reducing the global chemical footprint that impacts humans, animals, plants and the environment.
Sustainable production of molecules usually involves the biological processes of fermentation or bioconversion by enzymes. This approach can scale molecules that often cannot be scaled using regular agricultural techniques.
Conagen’s bio-production mission is to develop disruptive technology for producing products that improve humankind. Its science and innovation enable new applications and transform the way ingredients are sourced.
The company’s advantage in the synthetic biology space is its one-of-a-kind vertical integration business model with capacity to scale-up ingredient bioprocesses at multiple biomanufacturing sites worldwide.
More details at https://conagen.com/
-- BERNAMA
No comments:
Post a Comment